Yu ZQ - Search Results

1

Real-world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Tian H, Zhou L, Dai JW, Li Y, Gu CY, Kong DQ, Yu ZQ, Liu XF, Yin J. Tian H, et al. Among authors: yu zq. Br J Haematol. 2024 Oct 4. doi: 10.1111/bjh.19800. Online ahead of print. Br J Haematol. 2024. PMID: 39367620

2

Bortezomib, a promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment.

Yin J, Tian H, Kong D, Li Y, Gu C, Wang Z, Wu D, Yu Z. Yin J, et al. Br J Haematol. 2022 Nov;199(4):619-622. doi: 10.1111/bjh.18430. Epub 2022 Sep 8. Br J Haematol. 2022. PMID: 36076349 No abstract available.

3

Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant.

Tian H, Kong D, Li Y, Gu C, Yu Z, Wang Z, Wu D, Yin J. Tian H, et al. Platelets. 2022 Aug 18;33(6):951-953. doi: 10.1080/09537104.2021.2012140. Epub 2021 Dec 16. Platelets. 2022. PMID: 34915800 Free article.

4

The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient.

Yu X, Kong D, Wang Z, Yin J, Yu Z. Yu X, et al. Blood Coagul Fibrinolysis. 2022 Sep 1;33(6):348-350. doi: 10.1097/MBC.0000000000001137. Blood Coagul Fibrinolysis. 2022. PMID: 35981256 No abstract available.

5

Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia.

Kong D, Li Y, Fu C, Hou M, Yan L, Shang J, Wang Z, Yin J, Yu Z, Wu D. Kong D, et al. Leuk Lymphoma. 2022 Feb;63(2):491-494. doi: 10.1080/10428194.2021.1992766. Epub 2021 Oct 20. Leuk Lymphoma. 2022. PMID: 34668450 No abstract available.

6

Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study.

Liu X, Hou M, Li J, Jin J, Huang M, Yu Z, Xu X, Zhang X, Yang R. Liu X, et al. Platelets. 2022 Jan 2;33(1):82-88. doi: 10.1080/09537104.2020.1847267. Epub 2020 Nov 29. Platelets. 2022. PMID: 33251910 Free article. Clinical Trial.

7

A novel role of acellular hemoglobin in hemolytic thrombosis.

Wan Y, Wei Y, Zhang C, Liu Y, Xu L, Gu C, Yu Z, Yin J, Zhang Q, Deng W. Wan Y, et al. Thromb Res. 2023 Aug;228:33-41. doi: 10.1016/j.thromres.2023.05.024. Epub 2023 May 29. Thromb Res. 2023. PMID: 37267672

8

Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia.

Yang R, Li J, Jin J, Huang M, Yu Z, Xu X, Zhang X, Hou M. Yang R, et al. Br J Haematol. 2017 Jan;176(1):101-110. doi: 10.1111/bjh.14380. Epub 2016 Oct 13. Br J Haematol. 2017. PMID: 27734464 Free article. Clinical Trial.

9

Application of High-Throughput Sequencing in the Diagnosis of Inherited Thrombocytopenia.

Wang Q, Cao L, Sheng G, Shen H, Ling J, Xie J, Ma Z, Yin J, Wang Z, Yu Z, Chen S, Zhao Y, Ruan C, Xia L, Jiang M. Wang Q, et al. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):94S-103S. doi: 10.1177/1076029618790696. Epub 2018 Aug 13. Clin Appl Thromb Hemost. 2018. PMID: 30103613 Free PMC article. Clinical Trial.

10

[The Effect of VWF Propeptide on VWF Mutant in D1 Domain].

Yu XQ, Ma ZN, Ling J, Zhao YX, Yin J, Yu ZQ, Ruan CG. Yu XQ, et al. Among authors: yu zq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Oct;30(5):1541-1548. doi: 10.19746/j.cnki.issn.1009-2137.2022.05.037. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36208263 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters